Neuro-Oncology Reviews
Volume
26 Number 6
31 March 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 6, 31 March
Brunasso L, Avallone C, Florena AM, Grasso G.
Infratentorial
Relapsing Neuroglial Tumors in Adults: Management and Unsolved
Issues-A Systematic Review.
Brain
Sci. 2024 Mar 18;14(3):286. doi:
10.3390/brainsci14030286. PMID:
38539674. Review. ˍ
**Czarnywojtek A, Gut P, Dyrka K, Sowiński J, Sawicka-Gutaj
N, Katulska K, Stajgis P, Wykrętowicz M, Moskal J, Kościński
J, Pietrończyk K, Graczyk P, Krawczyński MR, Florek E,
Szczepanek-Parulska E, Ruchała M, Ferlito A.
Standard
therapy or additionally radioactive iodine (131I) therapy; which
will stop the recurrence of glioblastoma multiforme
(GBM)?
Endokrynol
Pol. 2024 Mar 19. doi:
10.5603/ep.98240. PMID:
38646982. Case report; Review. ˍ
Mulhem A.
Primary glioblastoma
multiform (GBM) of the optic nerve and chiasma: A case report and
systematic review of the literature.
Clin
Case Rep. 2024 Mar 20;12(3):e8636. doi:
10.1002/ccr3.8636. PMID:
38515994. Case report; Review.
ˍ
Pöhlmann J, Weller M, Marcellusi A, Grabe-Heyne K, Krott-Coi
L, Rabar S, Pollock RF.
High costs, low
quality of life, reduced survival, and room for improving
treatment: an analysis of burden and unmet needs in glioma.
Front
Oncol. 2024 Mar 20;14:1368606. doi:
10.3389/fonc.2024.1368606. PMID:
38571509. Review. ˍ
*Sun B, Sun Y, Wang Z, Zhao C, Yang L.
Prevalence
and risk factors of early postoperative seizures in patients with
glioma: a systematic review and meta-analysis.
Front
Neurol. 2024 Mar 20;15:1356715. doi:
10.3389/fneur.2024.1356715. PMID:
38572493. Review; Meta-analysis. ˍ
Tang
Q, Zhao G, Fang H, Jiang Y, Ma P, Zhou J, Liu D, Xing S, Li G, Liu
N, Chen H, Wang S, Li N.
Nanoparticle
drug delivery system for the treatment of brain tumors:
Breaching the blood-brain barrier.
Acta
Pharm Sin B.
2024 Mar 20;14(6):2786-2789. doi:
10.1016/j.apsb.2024.03.023. PMID:
38828158. Review. ˍ
Aghajani M, Jalilzadeh N, Aghebati-Maleki A, Yari A, Tabnak P,
Mardi A, Saeedi H, Aghebati-Maleki L, Baradaran B.
Current
approaches in glioblastoma multiforme immunotherapy.
Clin
Transl Oncol. 2024 Mar 21. doi:
10.1007/s12094-024-03395-7. PMID:
38512448. Review˰ ˍ
Rahman R, Shi DD, Reitman ZJ, Hamerlik P, de Groot JF, Haas-Kogan
DA, D'Andrea AD, Sulman EP, Tanner K, Agar NYR, Sarkaria JN,
Tinkle CL, Bindra RS, Mehta MP, Wen PY.
DNA
damage response in brain tumors: A Society for Neuro-Oncology
consensus review on mechanisms and translational efforts in
neuro-oncology.
Neuro
Oncol. 2024 Mar 22:noae072. doi:
10.1093/neuonc/noae072. PMID:
38770568. Review. ˍ
*Pons-Escoda A, Majos C, Smits M, Oleaga L.
Presurgical
diagnosis of diffuse gliomas in adults: Post-WHO 2021 practical
perspectives from radiologists in neuro-oncology units.
Radiologia
(Engl Ed). 2024 Mar 23;66(3):260-277. doi:
10.1016/j.rxeng.2024.03.002. PMID:
38908887. Review.
ˍ
Salvato I, Marchini A.
Immunotherapeutic
Strategies for the Treatment of Glioblastoma: Current Challenges
and Future Perspectives.
Cancers
(Basel). 2024 Mar 25;16(7):1276. doi:
10.3390/cancers16071276. PMID:
38610954. Review. ˍ
Begley SL, McBriar JD, Pelcher I, Schulder M.
Intraoperative
MRI: A Review of Applications Across Neurosurgical
Specialties.
Neurosurgery.
2024 Mar 26. doi:
10.1227/neu.0000000000002933. PMID:
38530004. Review˰ ˍ
Ohnishi T.
Current Status and Future
Perspective in Glioma Invasion Research.
Brain
Sci. 2024 Mar 26;14(4):309. doi:
10.3390/brainsci14040309. PMID:
38671961. Editorial. ˍ
*Watanabe S, Nonaka T, Maeda M, Yamada M, Sugii N, Hashimoto K,
Takano S, Koyanagi T, Arakawa Y, Ishikawa E.
Recent
Status of Phase I Clinical Trials for Brain Tumors: A Regulatory
Science Study of Exploratory Efficacy Endpoints.
Ther
Innov Regul Sci. 2024 Mar 26. doi:
10.1007/s43441-024-00644-3. PMID:
38530629. Review; Meta-analysis. ˍ
Fernandez-Gil BI, Larion M.
Editorial:
CNS tumor metabolism: targets, markers, and challenges.
Front
Cell Neurosci. 2024 Mar 27;18:1401687. doi:
10.3389/fncel.2024.1401687. PMID:
38601024. Editorial. ˍ
Heidari M, Shokrani P.
Imaging Role in
Diagnosis, Prognosis, and Treatment Response Prediction Associated
with High-grade Glioma.
J
Med Signals Sens. 2024 Mar 27;14:7. doi:
10.4103/jmss.jmss_30_22. PMID:
38993200. Review. ˍ
Nabavizadeh A, Galldiks N, Veronesi M, Lohmann P, McConathy JE,
Johnson DR, Aboian MS, Barajas RF Jr, Ivanidze J.
Introducing
the American Society of Neuroradiology PET-Guided Diagnosis and
Management in Neuro-Oncology Study Group.
AJNR
Am J Neuroradiol. 2024 Mar 28. doi:
10.3174/ajnr.A8243. PMID:
38548306. Editorial˰ ˍ
Schirrmacher V, Van Gool S, Stuecker W.
Individualized
Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical
Experience from a Single Institution.
Biomedicines.
2024 Mar 28;12(4):754. doi:
10.3390/biomedicines12040754. PMID:
38672110. Review. ˍ
Valerius AR, Webb LM, Sener U.
Novel
Clinical Trials and Approaches in the Management of
Glioblastoma.
Curr
Oncol Rep. 2024 Mar 28. doi:
10.1007/s11912-024-01519-4. PMID:
38546941. Review˰ ˍ
*Khalighi S, Reddy K, Midya A, Pandav KB, Madabhushi A,
Abedalthagafi M.
Artificial
intelligence in neuro-oncology: advances and challenges in brain
tumor diagnosis, prognosis, and precision treatment.
NPJ
Precis Oncol. 2024 Mar 29;8(1):80. doi:
10.1038/s41698-024-00575-0. PMID:
38553633. Review. ˍ
Menegaz de Almeida A, Viana P, Marinheiro G, Hoffmann Relvas J,
Lopes L, Lima Guilherme G, Zanette Giusti JA, Oliveira P, Azevedo
Silva Kaiser Cabral MA, Carvalho Santos R, Medani K.
Hypertonic
Saline Solution Versus Mannitol for Brain Relaxation During
Craniotomies: A Systematic Review and Updated
Meta-Analysis.
Neurosurgery.
2024 Mar 29. doi:
10.1227/neu.0000000000002929. PMID:
38551382. Review; Meta-Analysis˰
ˍ
Virtuoso A, D'Amico G, Scalia F, De Luca C, Papa M, Maugeri G,
D'Agata V, Caruso Bavisotto C, D'Amico AG.
The
Interplay between Glioblastoma Cells and Tumor Microenvironment:
New Perspectives for Early Diagnosis and Targeted Cancer
Therapy.
Brain
Sci. 2024 Mar 29;14(4):331. doi:
10.3390/brainsci14040331. PMID:
38671983. Review. ˍ
Katole VR, Kaple M.
Unraveling the
Landscape of Pediatric Glioblastoma Biomarkers: A Comprehensive
Review of Enhancing Diagnostics and Therapeutic Insights.
Cureus.
2024 Mar 30;16(3):e57272. doi:
10.7759/cureus.57272. PMID:
38686271. Review. ˍ
Liu Y, Tang Q, Tao Q, Dong H, Shi Z, Zhou L.
Low-frequency
magnetic field therapy for glioblastoma: Current advances,
mechanisms, challenges and future perspectives.
J
Adv Res. 2024 Mar 31:S2090-1232(24)00125-5. doi:
10.1016/j.jare.2024.03.024. PMID:
38565404. Review. ˍ